Yield10 Bioscience, Inc. (NASDAQ: YTEN) Stock Competitors & Peer Comparison

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, CTA-PA has a market cap of 59.8B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while CTA-PA trades at $53.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas CTA-PA's P/E ratio is N/A. In terms of profitability, YTEN's ROE is -15.08%, compared to CTA-PA's ROE of +0.05%. Regarding short-term risk, YTEN is more volatile compared to CTA-PA. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check CTA-PA's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, CTVA has a market cap of 59.7B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while CTVA trades at $89.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas CTVA's P/E ratio is 24.19. In terms of profitability, YTEN's ROE is -15.08%, compared to CTVA's ROE of +0.05%. Regarding short-term risk, YTEN is more volatile compared to CTVA. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check CTVA's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, CTA-PB has a market cap of 59.5B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while CTA-PB trades at $66.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas CTA-PB's P/E ratio is N/A. In terms of profitability, YTEN's ROE is -15.08%, compared to CTA-PB's ROE of +0.05%. Regarding short-term risk, YTEN is more volatile compared to CTA-PB. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check CTA-PB's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, NTR has a market cap of 32.7B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while NTR trades at $68.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas NTR's P/E ratio is 13.73. In terms of profitability, YTEN's ROE is -15.08%, compared to NTR's ROE of +0.09%. Regarding short-term risk, YTEN is more volatile compared to NTR. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check NTR's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, CF has a market cap of 19.2B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while CF trades at $125.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas CF's P/E ratio is 10.84. In terms of profitability, YTEN's ROE is -15.08%, compared to CF's ROE of +0.35%. Regarding short-term risk, YTEN is more volatile compared to CF. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check CF's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, MOS has a market cap of 7.1B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while MOS trades at $22.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas MOS's P/E ratio is 12.26. In terms of profitability, YTEN's ROE is -15.08%, compared to MOS's ROE of +0.06%. Regarding short-term risk, YTEN is more volatile compared to MOS. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check MOS's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, ICL has a market cap of 6.8B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while ICL trades at $5.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas ICL's P/E ratio is 13.54. In terms of profitability, YTEN's ROE is -15.08%, compared to ICL's ROE of +0.04%. Regarding short-term risk, YTEN is more volatile compared to ICL. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check ICL's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, SMG has a market cap of 4B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while SMG trades at $69.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas SMG's P/E ratio is 15.79. In terms of profitability, YTEN's ROE is -15.08%, compared to SMG's ROE of -0.34%. Regarding short-term risk, YTEN is more volatile compared to SMG. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check SMG's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, FMC has a market cap of 1.4B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while FMC trades at $11.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas FMC's P/E ratio is 4.43. In terms of profitability, YTEN's ROE is -15.08%, compared to FMC's ROE of -0.83%. Regarding short-term risk, YTEN is more volatile compared to FMC. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check FMC's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, UAN has a market cap of 1.3B. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while UAN trades at $123.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas UAN's P/E ratio is 10.62. In terms of profitability, YTEN's ROE is -15.08%, compared to UAN's ROE of +0.40%. Regarding short-term risk, YTEN is more volatile compared to UAN. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check UAN's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, GLAS has a market cap of 768.8M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while GLAS trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas GLAS's P/E ratio is -17.75. In terms of profitability, YTEN's ROE is -15.08%, compared to GLAS's ROE of N/A. Regarding short-term risk, YTEN is more volatile compared to GLAS. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check GLAS's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, IPI has a market cap of 459.8M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while IPI trades at $34.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas IPI's P/E ratio is 20.50. In terms of profitability, YTEN's ROE is -15.08%, compared to IPI's ROE of +0.03%. Regarding short-term risk, YTEN is more volatile compared to IPI. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check IPI's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, AFRIW has a market cap of 265.1M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while AFRIW trades at $0.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas AFRIW's P/E ratio is -40.00. In terms of profitability, YTEN's ROE is -15.08%, compared to AFRIW's ROE of +0.46%. Regarding short-term risk, YTEN is more volatile compared to AFRIW. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check AFRIW's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, AVD has a market cap of 73.4M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while AVD trades at $2.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas AVD's P/E ratio is -8.84. In terms of profitability, YTEN's ROE is -15.08%, compared to AVD's ROE of -0.22%. Regarding short-term risk, YTEN is more volatile compared to AVD. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check AVD's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, BHIL-WT has a market cap of 49M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while BHIL-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas BHIL-WT's P/E ratio is N/A. In terms of profitability, YTEN's ROE is -15.08%, compared to BHIL-WT's ROE of -0.82%. Regarding short-term risk, YTEN is less volatile compared to BHIL-WT. This indicates lower risk in terms of short-term price fluctuations for YTEN.Check BHIL-WT's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, BHST has a market cap of 32.6M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while BHST trades at $1.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas BHST's P/E ratio is -3.76. In terms of profitability, YTEN's ROE is -15.08%, compared to BHST's ROE of -0.88%. Regarding short-term risk, YTEN is more volatile compared to BHST. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check BHST's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, CGA has a market cap of 29.3M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while CGA trades at $1.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas CGA's P/E ratio is -0.98. In terms of profitability, YTEN's ROE is -15.08%, compared to CGA's ROE of +0.11%. Regarding short-term risk, YTEN is more volatile compared to CGA. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check CGA's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, BIOX has a market cap of 20.9M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while BIOX trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas BIOX's P/E ratio is -0.31. In terms of profitability, YTEN's ROE is -15.08%, compared to BIOX's ROE of -1.51%. Regarding short-term risk, YTEN is more volatile compared to BIOX. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check BIOX's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, LVRO has a market cap of 15.1M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while LVRO trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas LVRO's P/E ratio is -0.03. In terms of profitability, YTEN's ROE is -15.08%, compared to LVRO's ROE of +11.90%. Regarding short-term risk, YTEN is more volatile compared to LVRO. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check LVRO's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, SEED has a market cap of 7.6M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while SEED trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas SEED's P/E ratio is -0.99. In terms of profitability, YTEN's ROE is -15.08%, compared to SEED's ROE of +0.80%. Regarding short-term risk, YTEN is more volatile compared to SEED. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check SEED's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, SVFD has a market cap of 4.2M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while SVFD trades at $1.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas SVFD's P/E ratio is 0.07. In terms of profitability, YTEN's ROE is -15.08%, compared to SVFD's ROE of -367.30%. Regarding short-term risk, YTEN is more volatile compared to SVFD. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check SVFD's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, FMTO has a market cap of 3.1M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while FMTO trades at $3.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas FMTO's P/E ratio is -0.00. In terms of profitability, YTEN's ROE is -15.08%, compared to FMTO's ROE of -2.43%. Regarding short-term risk, YTEN is more volatile compared to FMTO. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check FMTO's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, BHIL has a market cap of 1.5M. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while BHIL trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas BHIL's P/E ratio is -0.01. In terms of profitability, YTEN's ROE is -15.08%, compared to BHIL's ROE of -0.82%. Regarding short-term risk, YTEN is more volatile compared to BHIL. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check BHIL's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, RKDA has a market cap of 990.3K. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while RKDA trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas RKDA's P/E ratio is -0.26. In terms of profitability, YTEN's ROE is -15.08%, compared to RKDA's ROE of -2.19%. Regarding short-term risk, YTEN is more volatile compared to RKDA. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check RKDA's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, NXTS has a market cap of 101.9K. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while NXTS trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas NXTS's P/E ratio is -0.04. In terms of profitability, YTEN's ROE is -15.08%, compared to NXTS's ROE of -0.86%. Regarding short-term risk, YTEN is more volatile compared to NXTS. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check NXTS's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, TNH has a market cap of 0. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while TNH trades at $83.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas TNH's P/E ratio is 10.13. In terms of profitability, YTEN's ROE is -15.08%, compared to TNH's ROE of +0.43%. Regarding short-term risk, YTEN is more volatile compared to TNH. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check TNH's competition here

Yield10 Bioscience, Inc. (NASDAQ: YTEN) plays a significant role within the Basic Materials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YTEN stands at 345.5K. In comparison, MBII has a market cap of 0. Regarding current trading prices, YTEN is priced at $0.34 on the NASDAQ, while MBII trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YTEN currently has a P/E ratio of -0.02, whereas MBII's P/E ratio is -6.82. In terms of profitability, YTEN's ROE is -15.08%, compared to MBII's ROE of -0.54%. Regarding short-term risk, YTEN is more volatile compared to MBII. This indicates higher risk in terms of short-term price fluctuations for YTEN.Check MBII's competition here